BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16902657)

  • 1. National All Schedules Prescription Electronic Reporting Act (NASPER): balancing substance abuse and medical necessity.
    Manchikanti L; Brown KR; Singh V
    Pain Physician; 2002 Jul; 5(3):294-319. PubMed ID: 16902657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the National All Schedules Prescription Electronic Reporting Act (NASPER): a public law for balancing treatment of pain and drug abuse and diversion.
    Manchikanti L; Whitfield E; Pallone F
    Pain Physician; 2005 Oct; 8(4):335-47. PubMed ID: 16850056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National drug control policy and prescription drug abuse: facts and fallacies.
    Manchikanti L
    Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of illicit drug use in patients without controlled substance abuse in interventional pain management.
    Manchikanti L; Pampati V; Damron KS; Beyer CD; Barnhill RC
    Pain Physician; 2003 Apr; 6(2):173-8. PubMed ID: 16883377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative evaluation of illicit drug use in patients with or without controlled substance abuse in interventional pain management.
    Manchikanti L; Damron KS; Beyer CD; Pampati V
    Pain Physician; 2003 Jul; 6(3):281-5. PubMed ID: 16880872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.
    Manchikanti L; Singh A
    Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of abuse of prescription and illicit drugs in chronic pain patients receiving short-acting (hydrocodone) or long-acting (methadone) opioids.
    Manchikanti L; Manchukonda R; Pampati V; Damron KS
    Pain Physician; 2005 Jul; 8(3):257-61. PubMed ID: 16850081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
    Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
    Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective.
    Manchikanti L; Fellows B; Ailinani H; Pampati V
    Pain Physician; 2010; 13(5):401-35. PubMed ID: 20859312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of prescription monitoring programs on chronic pain management.
    Wang J; Christo PJ
    Pain Physician; 2009; 12(3):507-15. PubMed ID: 19461820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does adherence monitoring reduce controlled substance abuse in chronic pain patients?
    Manchikanti L; Manchukonda R; Damron KS; Brandon D; McManus CD; Cash K
    Pain Physician; 2006 Jan; 9(1):57-60. PubMed ID: 16700282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of illicit drug use among individuals with chronic pain in the Commonwealth of Kentucky: an evaluation of patterns and trends.
    Manchikanti L; Fellows B; Damron KS; Pampati V; McManus CD
    J Ky Med Assoc; 2005 Feb; 103(2):55-62. PubMed ID: 15751456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to optimize pain management with opioids while minimizing risk of abuse.
    Brennan MJ; Stanos S
    PM R; 2010 Jun; 2(6):544-58. PubMed ID: 20630441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of the nonmedical use of prescription opioid analgesics.
    Gilson AM; Kreis PG
    Pain Med; 2009 Jul; 10 Suppl 2():S89-100. PubMed ID: 19691688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-medical use and abuse of commonly prescribed medications.
    Riggs P
    Curr Med Res Opin; 2008 Mar; 24(3):869-77. PubMed ID: 18267053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-medical use of OxyContin Tablets in the United States.
    Sees KL; Di Marino ME; Ruediger NK; Sweeney CT; Shiffman S
    J Pain Palliat Care Pharmacother; 2005; 19(2):13-23. PubMed ID: 16061457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active surveillance of abused and misused prescription opioids using poison center data: a pilot study and descriptive comparison.
    Hughes AA; Bogdan GM; Dart RC
    Clin Toxicol (Phila); 2007; 45(2):144-51. PubMed ID: 17364631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for the use of controlled substances in the management of chronic pain.
    Atluri S; Boswell MV; Hansen HC; Trescot AM; Singh V; Jordan AE
    Pain Physician; 2003 Jul; 6(3):233-57. PubMed ID: 16880868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.